Tag: Motley Fool

  • Qantas share price flies away from ‘unfair and unworkable’ flight credit claims

    a man sitting in an aeroplane seat holds the top of his head as he looks at his airline ticket with an annoyed, angry expression on his face.a man sitting in an aeroplane seat holds the top of his head as he looks at his airline ticket with an annoyed, angry expression on his face.

    The Qantas Airways Ltd (ASX: QAN) share price is higher today, now trading up 0.6% to $5.06.

    Qantas has shrugged off reports today the consumer advocacy group Choice has lodged a formal complaint with the Australian Competition and Consumer Commission (ACCC) against the airline.

    The complaint relates to Qantas’ flight credit policies which have been the topic of heated debate ever since the pandemic started.

    TradingView Chart

    ‘Unfair terms and deceptive conduct’

    Qantas has been pulled into the limelight today amid allegations its flight credits scheme is unfair to consumers and may breach contract terms.

    According to an update from the consumer advocacy group:

    CHOICE has filed a complaint with the ACCC calling out potentially misleading and deceptive conduct in Qantas’s credit redemption policy.

    Aside from the potentially unfair terms, Qantas customers have reported many problems in trying to use their flight credits.

    Choice spokesperson Dean Price said that Qantas was “placing unreasonable barriers in the way of travellers trying to redeem their credits or get a refund from cancelled travels”, the ABC reported today.

    Price said there were a number of concerns with the system, ranging from price concerns to factors like “unfair expiry dates”.

    Choice has conducted a number of surveys over the past few months and found that consumers faced numerous roadblocks when trying to redeem flight credits awarded from COVID-19 cancellations.

    “A series of CHOICE surveys over recent months, asking people questions about travel cancellations, have made one thing clear: many have hit obstacles when trying to use the Qantas flight credits they were given in place of refunds,” it found.

    “Others haven’t been able to use them at all.”

    One recent survey suggested “one in five [20%] customers have been entirely unable to use their credit”, Australian Aviation reports.

    Qantas allegedly changed the rules for future bookings for flights cancelled after 30 September 2021.

    Choice said that meant an original ticket had to be redeemed on flights of equal or substantially more value than initially booked, even if the same flight now cost less.

    For instance, if you have a $500 credit for a Sydney to Melbourne flight and the price is now $475, you wouldn’t be able to use the credit, even if you waived the $25 loss. Instead, you’d have to buy a new ticket and leave your credit untouched.

    And customers holding credits for international flights don’t have the option of spreading the credits across several domestic flights if they booked after 30 September 2021.

    The ACCC called for public evidence on the matter in March, following reports of “price gouging” raised by media outlets Nine and the ABC.

    Qantas share price snapshot

    The Qantas share price is down around 5% in the last 12 months of trade, climbing more than 1% higher this year to date.

    Australia’s national airline has a market capitalisation of $9.57 billion at its current share price.

    The post Qantas share price flies away from ‘unfair and unworkable’ flight credit claims appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Qantas right now?

    Before you consider Qantas, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Qantas wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of January 13th 2022

    More reading

    Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/R5inUt7

  • Why Iress, Krakatoa Resources, Paradigm, and SE Advanced Materials are pushing higher

    In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a disappointing decline. At the time of writing, the benchmark index is down 0.5% to 7,449.9 points.

    Four ASX shares that are not letting that hold them back today are listed below. Here’s why they are pushing higher:

    Iress Ltd (ASX: IRE)

    The Iress share price is up 2% to $11.82. This morning the financial technology company announced that it has decided against divesting its UK Mortgages business. Management believes the recent weakness in tech valuations means it will create more value retaining the business. Iress also reaffirmed its underlying net profit after tax growth guidance of 25% to 37% in FY 2022.

    Krakatoa Resources Ltd (ASX: KTA)

    The Krakatoa Resources share price has rocketed 117% to 12.8 cents. This morning the rare earths explorer reported that it has discovered “widespread clay hosted ionic type REE in the regolith” at its Mt Clere project in Western Australia.

    Paradigm Biopharmaceuticals Ltd (ASX: PAR)

    The Paradigm share price is up 20% to $1.39. This afternoon the biopharmaceutical company revealed that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for Paradigm’s phase 3 program investigating Pentosan Polysulfate Sodium (PPS) for the treatment of osteoarthritis (OA). The release highlights that the Fast Track Designation from the FDA acknowledges that OA can be a serious disease with an unmet medical need and that preliminary data demonstrate that PPS has the potential to address this unmet need.

    5E Advanced Materials Inc (ASX: 5EA)

    The 5E Advanced Materials share price is up 12% to $3.10. This morning the boron-focused advanced materials company entered into a research collaboration agreement with Georgetown University. The agreement will see the two parties aim to advance boron based materials research in permanent magnets.

    The post Why Iress, Krakatoa Resources, Paradigm, and SE Advanced Materials are pushing higher appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of January 12th 2022

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/0ras1zI

  • ‘Highly encouraged’: Why this ASX energy share is soaring 7% today

    Man with rocket wings which have flames coming out of them.Man with rocket wings which have flames coming out of them.

    Most ASX-listed energy shares are having a rough trot today after oil prices slumped overnight. However, 88 Energy Ltd (ASX: 88E) is one energy company that is firmly in the green.

    The oil and gas exploration company is currently fetching 1.6 cents per share, up 6.67% from its previous close.

    The notable move upward follows a production update from 88 Energy regarding Project Longhorn.

    From ASX exploration energy share to producer

    After a relatively disastrous start to the year, 88 Energy shares are experiencing a bounceback on Tuesday. The latest production update appears to have given investors something to get excited about once again.

    In its update, the company has provided the first glimpse into the acquisition of Texas oil and gas assets in the Permian Basin — Project Longhorn. Notably, the deal struck in February for US$9.7 million has officially turned 88 Energy into a producer.

    Specifically, Longhorn has surpassed 400 barrels of oil equivalent (BOE) per day gross at the end of March. Moreover, this milestone production metric represents more than a 30% increase in production since the small-cap ASX energy share took over the oil and gas assets.

    Highlighting the impact of this, the company stated:

    The production increase provides additional direct exposure to the higher WTI oil price environment and accelerates payback on both the acquisition of the assets and the capital investment in the work-overs.

    Project Longhorn has exceptionally low operating costs (lifting costs), which provides high margins from production.

    Lastly, investors are likely salivating at the proposition of 88 Energy deriving revenue from operations. Today, the company stated it received its first payout from Project Longhorn, which came to $0.6 million. This was net of operational and capital expenditure, as well as splitting with co-owner Lonestar I LLC.

    How has 88 Energy performed lately?

    Prior to March, shares in this ASX-listed energy company were performing remarkably well. In fact, 88 Energy had returned around 400% in a one-year timeframe. However, news of an oil no-show in its target zone of the Merlin-2 well sent shares spiralling downwards on 30 March.

    Now, ASX-listed 88 Energy is down 36% compared to this time a year ago.

    The post ‘Highly encouraged’: Why this ASX energy share is soaring 7% today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in 88 Energy right now?

    Before you consider 88 Energy, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and 88 Energy wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of January 13th 2022

    More reading

    Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/itkuE51

  • Why Amazon stock slipped on Monday

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    a warehouse worker wearing a face mask handles a cardboard box in an automated warehouse setting with equipment in the background.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    What happened

    Even within the giant US stock market, it’s not every day that a company announces an 11-figure bond issue. Monday was an exception, with Amazon (NASDAQ: AMZN) floating $12.75 billion of debt. For a company of Amazon’s size, that’s quite a bit of scratch and investors responded to the news by trading its stock down by more than 2% on the day.

    So what

    Amazon’s unsecured senior debt was issued in seven parts, all of which have different coupons and maturities. These range from 2.73% notes maturing in 2024 to 4.1% notes coming due in 2062. At least the interest payments are consistent throughout the series. For each, those disbursements will be effected on 13 April and 13 October of every year starting this October.

    In its prospectus on the notes, the retail sector giant wrote that it aims to use the proceeds

    for general corporate purposes, which may include, but are not limited to, repayment of debt, acquisitions, investments, working capital, investments in our subsidiaries, capital expenditures, and repurchases of outstanding shares of our common stock.

    Any, and even all, of those uses are necessary for Amazon’s functioning. At the end of 2021, the sprawling company had over $116 billion of outstanding debt to service. And in mid-March, it closed an $8.5 billion deal for what’s effectively a big film and TV content warehouse, MGM.

    Now what

    At the same time, though, Amazon’s encouraging recent fundamentals give the company balance-sheet strength. Its pile of cash and short-term investments rose to over $96 billion at the end of last year, a massive amount that was 11% higher year over year.

    Yes, $12.75 billion is a considerable figure and yes, interest rates aren’t as low as they used to be. But considerable figures are the rule and not the exception for Amazon, and the company has more than enough financial muscle and growth potential to handle them. The stock’s bulls shouldn’t fret about this move.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    The post Why Amazon stock slipped on Monday appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Amazon right now?

    Before you consider Amazon, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Amazon wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of January 13th 2022

    More reading

    John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Eric Volkman has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Amazon. The Motley Fool Australia has recommended Amazon. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    from The Motley Fool Australia https://ift.tt/Z2koy8H

  • Massive copper and zinc discovery sends this ASX mining share soaring 44%

    happy mining worker fortescue share pricehappy mining worker fortescue share price

    The Anax Metals Ltd (ASX: ANX) share price is exploding today on the back of ‘spectacular’ drilling results.

    The company’s shares are currently trading at 14 cents each, a 44% gain. In contrast, the S&P/ASX 200 Resources Index (ASX: XJR) is 0.57% in the red today.

    So why is this ASX mining share soaring today?

    Copper and zinc intersected

    Anax reported spectacular “massive” copper and zinc sulphide mineralisation at the company’s Whim Creek project.

    Drilling intersected mineralisation up to 15m wide at the Evelyn deposit and massive to semi-massive sulphides at the Salt Creek deposit.

    The project is located near Port Hedland in the West Pilbara region of Western Australia.

    Nine holes have been drilled at three of the four metal deposits at the project. Final assay results are still on the way.

    Commenting on the results, managing director Geoff Laing said:

    Initial observations from this latest round of diamond drilling have been very encouraging and while assay results are still awaited, intersection of massive copper and zinc sulphides and confirmation of historically defined mineralisation is exciting.

    The presence of copper, zinc, and also lead was confirmed via XRF scanning. Metallurgical test work is due to start very soon. The results will help form geotechnical data for feasibility studies.

    Share price snapshot

    Anax shares have surged 69% year to date and more than 84% in a year.

    For perspective, the ASX 200 Resources Index has returned around 15% over the past 52 weeks.

    In the past month, the company’s shares have risen 59%, leaping 44% in the past week alone.

    Anax has a market capitalisation of about $56 million based on the current share price.

    The post Massive copper and zinc discovery sends this ASX mining share soaring 44% appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Anax right now?

    Before you consider Anax, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Anax wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of January 13th 2022

    More reading

    The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/mcPlg3J

  • Why are brokers talking about the Xero share price? Let’s take a look

    a cute little boy with curly hair wearing a business suit with a tie and too big glasses looks intently at an old fashioned business calculator with a scroll of paper spilling onto his desktop.a cute little boy with curly hair wearing a business suit with a tie and too big glasses looks intently at an old fashioned business calculator with a scroll of paper spilling onto his desktop.

    The Xero Ltd (ASX: XRO) share price is tracking south today, now trading 1.46% lower at $100.03.

    Aside from a momentary gain over the past month, Xero shares are deep in the red and have a way to go before hitting their previous highs.

    But what are experts saying about the accounting software provider’s prospects? Let’s see.

    TradingView Chart

    Analysts say buy Xero

    Jefferies is bullish on the stock and reckons it is heavily undervalued at current prices. In a recent note, the investment bank cited market research it had conducted to gauge Xero’s user sentiment.

    Its findings noted that many small to medium-sized enterprises (SMEs) are users of Xero’s product and are satisfied with what’s on offer.

    The broker also likes Xero’s growth strategy, noting it could give the business access to a market of 33 million SMEs in North America.

    Meanwhile, analysts at Citi reckon the recent federal budget will be a net positive for the company. The broker seems to think because some SMEs can deduct a further 20% of digital costs until June 30, this could boost subscriber inflows to Xero.

    Bloomberg Intelligence analyst Matt Ingram is also constructive on the federal budget’s effect on Xero.

    Xero’s Australian sales growth might beat consensus’ 15% next year thanks to the government’s A$1 billion small business support to go digital.

    Called the ‘Introducing the Technology Investment Boost’, about 3.6 million businesses will be eligible vs. Xero’s current 1.2 million subscribers.

    Other analysts are constructive on the company as well, valuing Xero at $128.15 per share on average, according to Bloomberg consensus data. More than 56% say buy while another 25% say Xero is a hold. Three analysts urge clients to sell.

    Evans and Partners reckons Xero is worth $203 per share, whilst Jarden says the share price is around $150 a pop based on its calculations.

    The Xero share price has fallen more than 29% into the red over the past 12 months, also falling 29% this year to date.

    The post Why are brokers talking about the Xero share price? Let’s take a look appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Xero right now?

    Before you consider Xero, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Xero wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of January 13th 2022

    More reading

    Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Xero. The Motley Fool Australia owns and has recommended Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/ewxZFTs

  • What’s moving the Fenix Resources share price higher today?

    three young children weariing business suits, helmets and old fashioned aviator goggles wear aeroplane wings on their backs and jump with one arm outstretched into the air in an arid, sandy landscape.three young children weariing business suits, helmets and old fashioned aviator goggles wear aeroplane wings on their backs and jump with one arm outstretched into the air in an arid, sandy landscape.

    The Fenix Resources Ltd (ASX: FEX) share price is all over the map this morning.

    After leaping 7% higher in early trade, shares in the ASX resource explorer are currently up 1.8%, at just under 30 cents per share.

    There’s been plenty of investor interest, with more than $3.1 million worth of trades taking place so far today.

    Below we look at the activities report for the quarter ending 31 March that looks to be moving the Fenix Resources share price.

    What did Fenix report for the quarter?

    The Fenix Resources share price is in the green after the company reported it had shipped some 295,000 wet metric tonnes (wmt) of high-quality iron ore from its Iron Ridge project, located in Western Australia, over the three months.

    It received an average price for the iron ore of US$132.83 (AU$183) per dry metric tonne (dmt) free on board (FOB).

    Fenix ended the quarter with net cash of $85.6 million, up from $54.9 million as at 31 December last year. That works out to 16.6 cents per share, and management said it “expects to build on this solid position during the current quarter”.

    Commenting on the quarter just past, Fenix Resources managing director Rob Brierley said:

    A strong recovery in the iron ore price and a decrease in shipping costs has seen us generate some $31 million of cash for the quarter underpinned by a solid production performance.

    Fenix also benefited from some positive pricing adjustments from the December 2021 quarter, which validated our decision to operate at close to full capacity, despite the price weakness during that period.

    Looking ahead, Brierley added: “The current quarter has started positively with strong iron ore prices, and a shipment completed loading on 2 April 2022.”

    The company expects six shipments in the June quarter.

    As for dividends, the company’s last full year dividend, paid in September 2021, gives it a trailing dividend yield of 18%. A juicy yield that could be helping support the Fenix Resources share price.

    Fenix did not pay an interim dividend, as its policy is to distribute 50% to 80% of its after-tax profits as fully franked dividends and there were no franking credits available. Management will announce its decision on the full-year dividend for FY22 in August.

    Fenix Resources share price snapshot

    The Fenix Resources share price is up 18% since this time last month. By comparison, the All Ordinaries Index (ASX: XAO) has gained 4% over that same period.

    The post What’s moving the Fenix Resources share price higher today? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Fenix Resources right now?

    Before you consider Fenix Resources, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Fenix Resources wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of January 13th 2022

    More reading

    The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/9FdD3ZR

  • Leading brokers name 3 ASX shares to sell today

    Business man marking Sell on board and underlining it

    Business man marking Sell on board and underlining itYesterday we looked at three ASX shares brokers have given buy ratings to this week.

    Unfortunately, not all shares are in favour with brokers right now. Three that have just been given sell ratings are listed below. Here’s why these brokers are bearish on these ASX shares:

    Commonwealth Bank of Australia (ASX: CBA)

    According to a note out of Citi, its analysts have retained their sell rating and $90.75 price target on this banking giant’s shares. Citi has been looking at the banking sector and believes cash rate increases could support stronger than expected net interest margins in the near future. While this makes the broker bullish on a couple of the big four banks, it isn’t enough for a more positive rating on CBA. It continues to see its shares as expensive. The CBA share price is trading at $106.09 on Tuesday.

    Evolution Mining Ltd (ASX: EVN)

    A note out of Credit Suisse reveals that its analysts have retained their underperform rating but lifted their price target on this gold miner’s shares to $3.80. This follows a review of the resources sector which has seen the broker lift its gold price forecasts. However, while this has supported an increase in its valuation, it isn’t enough for a change of rating. The Evolution share price is fetching $4.45 this afternoon.

    Pro Medicus Limited (ASX: PME)

    Analysts at Goldman Sachs have retained their sell rating and $44.80 price target on this health imaging technology company’s shares. Goldman notes that Pro Medicus has signed a major $32 million eight-year deal with Inova Health System. While the broker was pleased with the deal, is a fan of the company, and is positive on its long term outlook, it believes its shares are expensive at 54x earnings. Particularly as it does not have sufficient visibility that recent win-rates can be sustained. The Pro Medicus share price is trading at $47.31 on Tuesday.

    The post Leading brokers name 3 ASX shares to sell today appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of January 12th 2022

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended Pro Medicus Ltd. The Motley Fool Australia owns and has recommended Pro Medicus Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/YwIWRsG

  • How is the Newcrest share price tracking in 2022?

    A man leaps from a stack of gold coins to the next, each one higher than the last.A man leaps from a stack of gold coins to the next, each one higher than the last.

    The Newcrest Mining Ltd (ASX: NCM) share price has enjoyed a strong 2022, driven by positive market conditions.

    This year to date, Newcrest shares have gained more than 13% in value.

    In comparison, the broader S&P/ASX 200 Index (ASX: XJO) is trading relatively flat over the same period.

    At the time of writing, Newcrest shares are swapping hands at $27.77 apiece, down 1.45%.

    Why has the Newcrest share price surged in recent times?

    A common theme among gold mining companies, the Newcrest share price has been boosted by the improvement in gold prices.

    Traditionally, investors flock to the yellow metal as a safe-haven asset when there is uncertainty in the market.

    While the world is slowly moving past COVID-19, geopolitical tensions between Russia and Ukraine has sparked a gold rush.

    In the past month, the price of gold soared above the US$2,000 barrier but has since fallen a touch under. Currently, gold is fetching US$1,952 an ounce.

    In comparison, at the start of the year, the precious metal was fetching US$1,829.05. This represents an increase of 6.7% over the three-and-a-half-month period.

    As such, Newcrest Star shares have risen from $24.48 since the beginning of the calendar year.

    Is this a buying opportunity?

    A couple of brokers weighed in on the Newcrest share price with varying price points late last month.

    The team at Morgan Stanley cut its 12-month price target by 1% to $33.70 for Newcrest shares. This implies an upside of around 21% based on the current share price.

    On the other hand, UBS lowered its outlook on Newcrest shares to ‘neutral’ from ‘buy’. However, the broker raised its rating by 2.3% to $27.10.

    It appears UBS believes that Newcrest shares are fully valued for the moment, with investors in agreeance.

    The post How is the Newcrest share price tracking in 2022? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Newcrest right now?

    Before you consider Newcrest, you’ll want to hear this.

    Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Newcrest wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

    *Returns as of January 13th 2022

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/3cpH9PO

  • ASX 200 healthcare shares were chronically ill last quarter. Take a look

    a woman rugged up in a woolen hat and gloves with a thermometer in her mouth props her hand under her chin as she looks dejectedly at the camera,, as though she is miserable from feeling sick.a woman rugged up in a woolen hat and gloves with a thermometer in her mouth props her hand under her chin as she looks dejectedly at the camera,, as though she is miserable from feeling sick.

    ASX 200 healthcare shares have struggled for the past six months, let’s face it. After peaking at 52-week highs of 47,760 back in September 2021, the S&P/ASX 200 Health Care Index (ASX: XHJ) now rests at 39,861. That’s a 16.5% decline over that time.

    In the meantime, other sectors – mining and financials in particular – have thrust well above the laggards in sectors like healthcare and tech.

    The divergence continues to widen as well. Since the onset of geopolitical conflict, commodity inflation, and a shifting interest rate cycle, ASX 200 healthcare shares are bottom-heavy and now trade near 52-week lows.

    TradingView Chart

    Pseudo-top performers

    Categorising the ‘top’ performers amongst this group is a bit of a fallacy. According to Bloomberg data, only one name – Cochlear Ltd (ASX: COH) – finished higher for the period, with a 5% gain.

    Otherwise, the basket faced heavy losses for the quarter. Indeed, ranking in terms of performance is more an exercise in ‘who fell more than the other’.

    In terms of percentage change, Telix Pharmaceuticals Ltd (ASX: TLX) took out top spot with a heavy 40.2% loss for the period. Telix now needs to gain 66.7% to return to its pre-January levels.

    But losses were heavy for the sector overall. The average loss for an ASX healthcare stock was 20.82% last quarter, calculated from Bloomberg data.

    Names such as Imugene Ltd (ASX: IMU), Nanosonics Ltd (ASX: NAN), Clinuvel Pharmaceuticals Ltd (ASX: CUV), and Fisher & Paykel Healthcare Corp. Ltd (ASX: FPH) each fell further than the average.

    Meanwhile, CSL Ltd (ASX: CSL), Ramsay Health Care Ltd (ASX: RHC), and ResMed Inc (ASX: RMD) managed to close out the quarter in much less pain.

    Returns for the group and respective tickers for the top 10 performers last quarter are plotted below, in descending order.

    TradingView Chart

    Not only that, but earnings per share (EPS) for the sector is estimated to slide further in 2022, after already taking a backward step since September 2021.

    According to Bloomberg consensus data, by this time next year, analysts are forecasting the healthcare sector’s EPS to slide another 17% on average.

    Curiously, the data also shows the consensus of analyst estimates predicts a negative 17 cents EPS for Telix in the next period and Imugene a negative 1 cent per share EPS loss. That’s in line with the EPS loss of 20 cents in 2020 for Telix but behind 2019’s result.

    Meanwhile, CSL and Cochlear are estimated to deliver a $6.87 and $4.28 EPS result in the next period, according to Bloomberg consensus data.

    The post ASX 200 healthcare shares were chronically ill last quarter. Take a look appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

    *Returns as of January 12th 2022

    More reading

    Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended CSL Ltd., Cochlear Ltd., and Nanosonics Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia owns and has recommended Nanosonics Limited. The Motley Fool Australia has recommended Cochlear Ltd., Ramsay Health Care Limited, and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    from The Motley Fool Australia https://ift.tt/tndVkAW